Literature DB >> 15789195

Pharmacological treatments of pathological gambling.

Eric Hollander1, Erica Sood, Stefano Pallanti, Nicolo Baldini-Rossi, Bryann Baker.   

Abstract

Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15789195     DOI： 10.1007/s10899-004-1932-8

Source DB:  PubMed          Journal:  J Gambl Stud        ISSN： 1050-5350


  22 in total

1.  A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

Authors:  G Perna; A Bertani; D Caldirola; E Smeraldi; L Bellodi
Journal:  Pharmacopsychiatry       Date:  2001-05       Impact factor: 5.788

2.  Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder.

Authors:  S A Montgomery; S Kasper; D J Stein; K Bang Hedegaard; O M Lemming
Journal:  Int Clin Psychopharmacol       Date:  2001-03       Impact factor: 1.659

3.  Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.

Authors:  J Zohar; R Judge
Journal:  Br J Psychiatry       Date:  1996-10       Impact factor: 9.319

4.  Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders.

Authors:  Eric Hollander; Katherine A Tracy; Alan C Swann; Emil F Coccaro; Susan L McElroy; Patricia Wozniak; Kenneth W Sommerville; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

5.  Citalopram for social phobia: a clinical case series.

Authors:  N M Simon; S G Sharma; J J Worthington; P C Marzol; M H Pollack
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-10       Impact factor: 5.067

6.  A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.

Authors:  E Hollander; C M DeCaria; J N Finkell; T Begaz; C M Wong; C Cartwright
Journal:  Biol Psychiatry       Date:  2000-05-01       Impact factor: 13.382

7.  An open trial of valproate in borderline personality disorder.

Authors:  D J Stein; D Simeon; M Frenkel; M N Islam; E Hollander
Journal:  J Clin Psychiatry       Date:  1995-11       Impact factor: 4.384

8.  Lithium and valproate treatment of pathological gambling: a randomized single-blind study.

Authors:  Stefano Pallanti; Leonardo Quercioli; Erica Sood; Eric Hollander
Journal:  J Clin Psychiatry       Date:  2002-07       Impact factor: 4.384

9.  Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.

Authors:  Stefano Pallanti; Nicolò Baldini Rossi; Erica Sood; Eric Hollander
Journal:  J Clin Psychiatry       Date:  2002-11       Impact factor: 4.384

10.  A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.

Authors:  Suck Won Kim; Jon E Grant; David E Adson; Young Chul Shin; Rocco Zaninelli
Journal:  J Clin Psychiatry       Date:  2002-06       Impact factor: 4.384
View more
  7 in total

1.  Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.

Authors:  Birgit Abler; Georg Grön; Antonie Hartmann; Coraline Metzger; Martin Walter
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

Review 2.  Salvinorin A analogs as probes in opioid pharmacology.

Authors:  Thomas E Prisinzano; Richard B Rothman
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

3.  Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity.

Authors:  Walter Adriani; Emilia Romano; Mariangela Pucci; Esterina Pascale; Luca Cerniglia; Silvia Cimino; Renata Tambelli; Paolo Curatolo; Oleg Granstrem; Mauro Maccarrone; Giovanni Laviola; Claudio D'Addario
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08-18       Impact factor: 4.785

Review 4.  Brain imaging studies in pathological gambling.

Authors:  Ruth J van Holst; Wim van den Brink; Dick J Veltman; Anna E Goudriaan
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

Review 5.  An overview of gambling disorder: from treatment approaches to risk factors.

Authors:  José M Menchon; Gemma Mestre-Bach; Trevor Steward; Fernando Fernández-Aranda; Susana Jiménez-Murcia
Journal:  F1000Res       Date:  2018-04-09

6.  Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.

Authors:  Walter Adriani; Susanne Koot; Sandra Columba-Cabezas; Emilia Romano; Domenica Travaglini; Ruud van den Bos; Oleg Granstrem; Syed F Ali; Giovanni Laviola
Journal:  Behav Brain Funct       Date:  2012-11-28       Impact factor: 3.759

Review 7.  Nonhuman gamblers: lessons from rodents, primates, and robots.

Authors:  Fabio Paglieri; Elsa Addessi; Francesca De Petrillo; Giovanni Laviola; Marco Mirolli; Domenico Parisi; Giancarlo Petrosino; Marialba Ventricelli; Francesca Zoratto; Walter Adriani
Journal:  Front Behav Neurosci       Date:  2014-02-11       Impact factor: 3.558
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.